{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T13:21:34Z","timestamp":1740144094039,"version":"3.37.3"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"This study was funded by Xinjiang Tefeng Pharmaceutical Company, Ltd."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Drug Investig"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1007\/s40261-023-01276-5","type":"journal-article","created":{"date-parts":[[2023,6,4]],"date-time":"2023-06-04T08:01:18Z","timestamp":1685865678000},"page":"421-433","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Safety, Pharmacokinetics, and Pharmacodynamics of Midazolam Gel After Rectal Administration in Healthy Chinese Subjects"],"prefix":"10.1007","volume":"43","author":[{"given":"Sufeng","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinying","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaodi","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lijun","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuqing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sijia","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aiping","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yajuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8861-7299","authenticated-orcid":false,"given":"Feng","family":"Shao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,6,4]]},"reference":[{"issue":"4","key":"1276_CR1","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1046\/j.1365-2125.2002.01665.x","volume":"54","author":"M Pecking","year":"2002","unstructured":"Pecking M, Montestruc F, Marquet P, Wodey E, Homery M-C, Dostert P. Absolute bioavailability of midazolam after subcutaneous administration to healthy volunteers. Br J Clin Pharmacol. 2002;54(4):357\u201362.","journal-title":"Br J Clin Pharmacol"},{"key":"1276_CR2","doi-asserted-by":"crossref","unstructured":"Conway A, Rolley J, Sutherland JR. Midazolam for sedation before procedures. Cochrane Database Syst Rev. 2016;2016(5):CD009491.","DOI":"10.1002\/14651858.CD009491.pub2"},{"key":"1276_CR3","unstructured":"Kabi F. Midazolam injection, USP Rx only. 2017. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2017\/208878Orig1s000lbl.pdf. Accessed 3 May 2023."},{"issue":"1","key":"1276_CR4","doi-asserted-by":"publisher","first-page":"3503","DOI":"10.1038\/s41598-017-03154-5","volume":"7","author":"M Balk","year":"2017","unstructured":"Balk M, Hentschke H, Rudolph U, Antkowiak B, Drexler B. Differential depression of neuronal network activity by midazolam and its main metabolite 1-hydroxymidazolam in cultured neocortical slices. Sci Rep. 2017;7(1):3503.","journal-title":"Sci Rep"},{"issue":"6","key":"1276_CR5","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/clpt.1992.84","volume":"51","author":"JW Mandema","year":"1992","unstructured":"Mandema JW, Tuk B, van Steveninck AL, Breimer DD, Cohen AF, Danhof M. Pharmacokinetic-pharmacodynamic modeling of the central nervous system effects of midazolam and its main metabolite alpha-hydroxymidazolam in healthy volunteers. Clin Pharmacol Ther. 1992;51(6):715\u201328.","journal-title":"Clin Pharmacol Ther"},{"key":"1276_CR6","doi-asserted-by":"publisher","unstructured":"Singh SK, Dixit T. Pharmacogenomics in anesthesia. In: Handbook of pharmacogenomics and stratified medicine. Elsevier Inc.; 2014. p. 815\u201333. https:\/\/doi.org\/10.1016\/B978-0-12-386882-4.00035-9.","DOI":"10.1016\/B978-0-12-386882-4.00035-9"},{"key":"1276_CR7","doi-asserted-by":"publisher","first-page":"40224","DOI":"10.1074\/jbc.R112.386664","volume":"287","author":"E Sigel","year":"2012","unstructured":"Sigel E, Steinmann ME. Structure, function, and modulation of GABAA receptors. J Biol Chem. 2012;287:40224\u201331.","journal-title":"J Biol Chem"},{"key":"1276_CR8","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1111\/anae.14318","volume":"73","author":"S Salman","year":"2018","unstructured":"Salman S, Tang EKY, Cheung LC, Nguyen MN, Sommerfield D, Slevin L, et al. A novel, palatable paediatric oral formulation of midazolam: pharmacokinetics, tolerability, efficacy and safety. Anaesthesia. 2018;73:1469\u201377.","journal-title":"Anaesthesia"},{"issue":"4","key":"1276_CR9","first-page":"344","volume":"17","author":"CM Geiger","year":"2013","unstructured":"Geiger CM, Sorenson B, Whaley PA. Stability of midazolam in syrspend SF and syrspend SF cherry. Int J Pharm Compd. 2013;17(4):344\u20136.","journal-title":"Int J Pharm Compd"},{"issue":"2","key":"1276_CR10","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/0002-9343(94)90029-9","volume":"97","author":"KR Johnston","year":"1994","unstructured":"Johnston KR, Govel LA, Andritz MH. Gastrointestinal effects of sorbitol as an additive in liquid medications. Am J Med. 1994;97(2):185\u201391.","journal-title":"Am J Med"},{"key":"1276_CR11","doi-asserted-by":"publisher","first-page":"97","DOI":"10.2147\/CCIDE.S64250","volume":"7","author":"T Nelson","year":"2015","unstructured":"Nelson T, Xu Z. Pediatric dental sedation: challenges and opportunities. Clin Cosmet Investig Dent. 2015;7:97\u2013106.","journal-title":"Clin Cosmet Investig Dent"},{"issue":"3","key":"1276_CR12","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/BF00679782","volume":"37","author":"K Payne","year":"1989","unstructured":"Payne K, Mattheyse FJ, Liebenberg D, Dawes T. The pharmacokinetics of midazolam in paediatric patients. Eur J Clin Pharmacol. 1989;37(3):267\u201372.","journal-title":"Eur J Clin Pharmacol"},{"issue":"3","key":"1276_CR13","first-page":"338","volume":"40","author":"YX Duan","year":"2013","unstructured":"Duan YX, Li Q, Zheng AP, Zhu XW. Pharmacokinetics and the absolute bioavailability of midazolam rectal gel in rabbits. J Int Pharm Res. 2013;40(3):338\u201343.","journal-title":"J Int Pharm Res."},{"key":"1276_CR14","unstructured":"Administration USF and D. Draft guidance for industry\u2014general considerations for pediatric studies for drugs and biological products. 2014. https:\/\/www.fda.gov\/media\/90358\/download. Accessed 05 May 2023."},{"key":"1276_CR15","unstructured":"Thorpy MJ, Ahmed I. Chapter 2\u2014Approach to the patient with a sleep disorder. In: Barkoukis TJ, Matheson JK, Ferber R, Doghramji KBT-T in SM, editors. Philadelphia: W.B. Saunders; 2012. p. 10\u201327. https:\/\/www.sciencedirect.com\/science\/article\/pii\/B9781437717037100027."},{"issue":"4","key":"1276_CR16","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/00004714-199008000-00003","volume":"10","author":"DA Chernik","year":"1990","unstructured":"Chernik DA, Gillings D, Laine H, Hendler J, Silver JM, Davidson AB, et al. Validity and reliability of the Observer\u2019s Assessment of Alertness\/Sedation Scale: study with intravenous midazolam. J Clin Psychopharmacol. 1990;10(4):244\u201351.","journal-title":"J Clin Psychopharmacol"},{"issue":"2","key":"1276_CR17","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1067\/mge.2000.107284","volume":"52","author":"AL Bower","year":"2000","unstructured":"Bower AL, Ripepi A, Dilger J, Boparai N, Brody FJ, Ponsky JL. Bispectral index monitoring of sedation during endoscopy. Gastrointest Endosc. 2000;52(2):192\u20136.","journal-title":"Gastrointest Endosc"},{"issue":"4","key":"1276_CR18","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1093\/bja\/aev306","volume":"115","author":"TK Kim","year":"2015","unstructured":"Kim TK, Niklewski PJ, Martin JF, Obara S, Egan TD. Enhancing a sedation score to include truly noxious stimulation: the Extended Observer\u2019s Assessment of Alertness and Sedation (EOAA\/S). BJA Br J Anaesth. 2015;115(4):569\u201377.","journal-title":"BJA Br J Anaesth."},{"issue":"1","key":"1276_CR19","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.chest.2018.09.015","volume":"155","author":"NJ Pastis","year":"2019","unstructured":"Pastis NJ, Yarmus LB, Schippers F, Ostroff R, Chen A, Akulian J, et al. Safety and efficacy of Remimazolam compared with placebo and midazolam for moderate sedation during bronchoscopy. Chest. 2019;155(1):137\u201346.","journal-title":"Chest"},{"key":"1276_CR20","doi-asserted-by":"crossref","unstructured":"Litman RS, Cohen DE, Sclabassi RJ. Chapter 9\u2014Pediatric anesthesia equipment and monitoring. In: Motoyama EK, Davis PJ, editors. Smith\u2019s anesthesia for infants child. 7th Ed. Philadelphia: Mosby; 2006. p. 272\u2013318. https:\/\/www.sciencedirect.com\/science\/article\/pii\/B978032302647550014X","DOI":"10.1016\/B978-032302647-5.50014-X"},{"issue":"2","key":"1276_CR21","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/S0196-0644(03)00721-2","volume":"43","author":"D Agrawal","year":"2004","unstructured":"Agrawal D, Feldman HA, Krauss B, Waltzman ML. Bispectral index monitoring quantifies depth of sedation during emergency department procedural sedation and analgesia in children. Ann Emerg Med. 2004;43(2):247\u201355.","journal-title":"Ann Emerg Med"},{"issue":"1","key":"1276_CR22","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1213\/00000539-200201000-00024","volume":"94","author":"D Nieuwenhuijs","year":"2002","unstructured":"Nieuwenhuijs D, Coleman EL, Douglas NJ, Drummond GB, Dahan A. Bispectral index values and spectral edge frequency at different stages of physiologic sleep. Anesth Analg. 2002;94(1):125\u20139.","journal-title":"Anesth Analg"},{"issue":"7","key":"1276_CR23","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1023\/A:1012120421395","volume":"14","author":"W Krzyzanski","year":"1997","unstructured":"Krzyzanski W, Jusko WJ. Application of moment analysis to the sigmoid effect model for drug administered intravenously. Pharm Res. 1997;14(7):949\u201352.","journal-title":"Pharm Res"},{"issue":"10","key":"1276_CR24","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1007\/s11095-021-03118-5","volume":"38","author":"MC Mukashyaka","year":"2021","unstructured":"Mukashyaka MC, Wu C-L, Ha K, Zhang J, Wood J, Foley S, et al. Pharmacokinetic\/pharmacodynamic modeling of a cell-penetrating peptide phosphorodiamidate morpholino oligomer in mdx mice. Pharm Res. 2021;38(10):1731\u201345.","journal-title":"Pharm Res"},{"issue":"1","key":"1276_CR25","doi-asserted-by":"publisher","first-page":"27","DOI":"10.5698\/1535-7597.18.1.27","volume":"18","author":"KC Nickels","year":"2018","unstructured":"Nickels KC. Less effective and more expensive: is it time to move on from rectal diazepam? Epilepsy Curr. 2018;18(1):27\u20138.","journal-title":"Epilepsy Curr."},{"issue":"2","key":"1276_CR26","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/S0196-0644(94)70034-6","volume":"23","author":"RA Dieckmann","year":"1994","unstructured":"Dieckmann RA. Rectal diazepam for prehospital pediatric status epilepticus. Ann Emerg Med. 1994;23(2):216\u201324.","journal-title":"Ann Emerg Med"},{"issue":"9","key":"1276_CR27","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000025033","volume":"100","author":"Q Nie","year":"2021","unstructured":"Nie Q, Hui P, Ding H, Wang Z. Rectal chloral hydrate sedation for computed tomography in young children with head trauma. Medicine (Baltimore). 2021;100(9): e25033.","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"1276_CR28","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jemermed.2018.04.025","volume":"55","author":"SHF Lam","year":"2018","unstructured":"Lam SHF, Li DR, Hong CE, Vilke GM. Systematic review: rectal administration of medications for pediatric procedural sedation. J Emerg Med. 2018;55(1):51\u201363.","journal-title":"J Emerg Med"},{"issue":"4","key":"1276_CR29","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1177\/0018578719901276","volume":"56","author":"S Belo","year":"2021","unstructured":"Belo S, Touchard J, Secretan P-H, Vidal F, Boudy V, Cisternino S, et al. Stability of pentobarbital hydrogel for rectal administration in pediatric procedural sedation. Hosp Pharm. 2021;56(4):332\u20137.","journal-title":"Hosp Pharm"},{"issue":"5","key":"1276_CR30","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1007\/s00228-017-2197-3","volume":"73","author":"F Shao","year":"2017","unstructured":"Shao F, Zhang H, Xie L, Chen J, Zhou S, Zhang J, et al. Pharmacokinetics of ginkgolides A, B and K after single and multiple intravenous infusions and their interactions with midazolam in healthy Chinese male subjects. Eur J Clin Pharmacol. 2017;73(5):537\u201346.","journal-title":"Eur J Clin Pharmacol."},{"issue":"2\u20133","key":"1276_CR31","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.eplepsyres.2008.10.005","volume":"83","author":"DP Wermeling","year":"2009","unstructured":"Wermeling DP, Record KA, Archer SM, Rudy AC. A pharmacokinetic and pharmacodynamic study, in healthy volunteers, of a rapidly absorbed intranasal midazolam formulation. Epilepsy Res. 2009;83(2\u20133):124\u201332.","journal-title":"Epilepsy Res"},{"issue":"3","key":"1276_CR32","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/S0736-4679(97)00022-X","volume":"15","author":"SP Nordt","year":"1997","unstructured":"Nordt SP, Clark RF. Midazolam: a review of therapeutic uses and toxicity. J Emerg Med. 1997;15(3):357\u201365.","journal-title":"J Emerg Med"},{"issue":"4","key":"1276_CR33","doi-asserted-by":"publisher","first-page":"285","DOI":"10.2165\/00003088-198207040-00002","volume":"7","author":"AG de Boer","year":"1982","unstructured":"de Boer AG, Moolenaar F, de Leede LGJ, Breimer DD. Rectal drug administration: clinical pharmacokinetic considerations. Clin Pharmacokinet. 1982;7(4):285\u2013311.","journal-title":"Clin Pharmacokinet"},{"key":"1276_CR34","doi-asserted-by":"publisher","first-page":"106006","DOI":"10.1016\/j.ejps.2021.106006","volume":"167","author":"J Zhu","year":"2021","unstructured":"Zhu J, Zhao Y, Wang L, Zhou C, Zhou S, Chen T, et al. Physiologically based pharmacokinetic\/pharmacodynamic modeling to evaluate the absorption of midazolam rectal gel. Eur J Pharm Sci. 2021;167:106006.","journal-title":"Eur J Pharm Sci."},{"issue":"6","key":"1276_CR35","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1097\/00000542-200612000-00013","volume":"105","author":"MYM Peeters","year":"2006","unstructured":"Peeters MYM, Prins SA, Knibbe CAJ, Dejongh J, Math\u00f4t RAA, Warris C, et al. Pharmacokinetics and pharmacodynamics of midazolam and metabolites in nonventilated infants after craniofacial surgery. Anesthesiology. 2006;105(6):1135\u201346.","journal-title":"Anesthesiology"},{"key":"1276_CR36","unstructured":"FDA. Guidance for industry: exposure\u2013response relationships\u2014study design, data analysis and regulatory applications. FDA Guidance. 2003. https:\/\/www.fda.gov\/media\/71277\/download. Accessed 05 May 2023."},{"key":"1276_CR37","unstructured":"Mathur S, Patel J, Goldstein S et al. Bispectral index. Treasure Isl. StatPearls Publishing. 2022. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK539809\/. Accessed 05 May 2023."},{"issue":"1","key":"1276_CR38","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.neuroscience.2009.06.025","volume":"163","author":"O Chudomel","year":"2009","unstructured":"Chudomel O, Herman H, Nair K, Mosh\u00e9 SL, Galanopoulou AS. Age- and gender-related differences in GABAA receptor-mediated postsynaptic currents in GABAergic neurons of the substantia nigra reticulata in the rat. Neuroscience. 2009;163(1):155\u201367.","journal-title":"Neuroscience"},{"issue":"2","key":"1276_CR39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0017213","volume":"6","author":"V Ignjatovic","year":"2011","unstructured":"Ignjatovic V, Lai C, Summerhayes R, Mathesius U, Tawfilis S, Perugini MA, et al. Age-related differences in plasma proteins: how plasma proteins change from neonates to adults. PLoS ONE. 2011;6(2): e17213.","journal-title":"PLoS ONE"},{"issue":"2","key":"1276_CR40","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1124\/pharmrev.120.000071","volume":"73","author":"BD van Groen","year":"2021","unstructured":"van Groen BD, Nicola\u00ef J, Kuik AC, Van Cruchten S, van Peer E, Smits A, et al. Ontogeny of hepatic transporters and drug-metabolizing enzymes in humans and in nonclinical species. Pharmacol Rev. 2021;73(2):597\u2013678.","journal-title":"Pharmacol Rev"}],"container-title":["Clinical Drug Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-023-01276-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40261-023-01276-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-023-01276-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,27]],"date-time":"2023-06-27T11:32:51Z","timestamp":1687865571000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40261-023-01276-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["1276"],"URL":"https:\/\/doi.org\/10.1007\/s40261-023-01276-5","relation":{},"ISSN":["1173-2563","1179-1918"],"issn-type":[{"type":"print","value":"1173-2563"},{"type":"electronic","value":"1179-1918"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"14 May 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Sufeng Zhou, Jinying Zhu, Xiaodi Sun, Lijun Xie, Yuqing Zhao, Sijia Ding, Lu Wang, Juan Chen, Bei Zhu, Chen Zhou, and Feng Shao are employees of the First Affiliated Hospital with Nanjing Medical University. Aiping Zheng is an employee of the Institute of Pharmacology and Toxicology of Academy of Military Medical Sciences. Yajuan Li is an employee of Xinjiang Tefeng Pharmaceutical Company, Ltd. The authors report no other\u00a0conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"This study was funded by Xinjiang Tefeng Pharmaceutical Company, Ltd.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The data are not available in a repository, but reasonable requests can be directed to Feng Shao at jsphshaofeng@hotmail.com.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"This study was conducted according to Good Clinical Practice (GCP) following the tenets of the Declaration of Helsinki. The study was registered at chinadrugtrials.org.cn (CTR20192350). The protocol and informed consent form were approved by the Ethics Committee of the First Affiliated Hospital with Nanjing Medical University (Nanjing, China).","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All subjects provided written informed consent before any study-related procedures were conducted.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"Conceptualization: FS, CZ, SZ. Methodology, material preparation and data collection: SZ, XS, LX, SD, LW, JC, BZ, AZ. Data analysis: JZ. Writing-original draft preparation: JZ. Writing-review and editing: SZ, JZ. Resources: YL. Supervision: FS. All authors approved the final version of the manuscript.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}}]}}